‘Shark Tank’ preview: SynDaver Labs shocks Kevin O’Leary … but how?

Maybe SynDaver Labs really does offer a superior product, and by that, we mean a very lifelike synthetic cadaver that can be used for research or study purposes. With that being said, we are still admittedly surprised that they are on Friday night’s new “Shark Tank” episode. When you think of products that appeal to mass consumers, synthetic cadavers are not high on the list. Also, they are not cheap.

This business is not altogether cheap either, given that this business is coming into the Tank with a valuation of $30 million! There are some genuine sales as proof-of-concept, but this is the end of the good news. As a clip over at Entertainment Weekly shows, their company CEO is not even that interested in making big profits in the short-term. His focus is more on proper medical training and outreach. This is great when it comes to actually paying it forward and providing a good product for those who need it, but also bad for business. The show is not called the “Charity Tank” for a reason.

The struggle we see this business having is therefore an investor and the company finding a good balance where they can continue to do good and deliver a fantastic product, but in a way that is actually profitable and worth such a heavy price tag. The idea of a business not focusing on profits is enough to turn Kevin O’Leary into a cadaver!

This is ultimately going to be an interesting segment to watch just from the standpoint of risk. This is not a company that is unproven, and there is obviously a market out there. It just comes down to knowing it, investing in a long-term plan, and figuring out more ways to make money.

You can head over here to preview tonight’s “Shark Tank” episode further! Also, sign up now to acquire some other TV updates on all we cover via our CarterMatt Newsletter. (Photo: ABC.)